TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-3.84%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$6.16B
AUM Growth
+$1.7B
(+38%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
31.18%
Top 10 Holdings %
Top 10 Hldgs %
26.62%
Holding
7,028
New
637
Increased
3,226
Reduced
2,160
Closed
577
Top Buys
| 1 |
Apple
AAPL
|
+$180M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$87.1M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$85.5M |
| 5 |
Tesla
TSLA
|
+$63.1M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$48M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$23.8M |
| 3 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$21.4M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$17.7M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$13.1M |
Sector Composition
| 1 | Technology | 27.01% |
| 2 | Healthcare | 10.86% |
| 3 | Consumer Discretionary | 10.71% |
| 4 | Financials | 8.62% |
| 5 | Communication Services | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Hudbay
HBM
$5.33B
| $39K | ﹤0.01% |
9,611
-1,751
| -15% | -$7.11K |
|
3377
Immuneering
IMRX
$362M
| $39K | ﹤0.01% |
2,717
-111
| -4% | -$1.59K |
|
3378
Kiniksa Pharmaceuticals
KNSA
$2.64B
| $39K | ﹤0.01% |
3,077
-1,203
| -28% | -$15.2K |
|
3379
Kornit Digital
KRNT
$664M
| $39K | ﹤0.01% |
+1,480
| New | +$39K |
|
|
ONL
3380
Orion Office REIT
ONL
$156M
| $39K | ﹤0.01% |
4,513
-8,983
| -67% | -$77.6K |
|
3381
Paysign
PAYS
$320M
| $39K | ﹤0.01% |
16,382
+12,086
| +281% | +$28.8K |
|
|
PLYM
3382
Plymouth Industrial REIT
PLYM
$977M
| $39K | ﹤0.01% |
2,337
+989
| +73% | +$16.5K |
|
3383
Praxis Precision Medicines
PRAX
$961M
| $39K | ﹤0.01% |
1,136
+211
| +23% | +$7.24K |
|
3384
Rigel Pharmaceuticals
RIGL
$618M
| $39K | ﹤0.01% |
3,288
-7,706
| -70% | -$91.4K |
|
3385
Ryanair
RYAAY
$30.1B
| $39K | ﹤0.01% |
1,683
-7,577
| -82% | -$176K |
|
3386
TaskUs
TASK
$1.58B
| $39K | ﹤0.01% |
2,410
-344
| -12% | -$5.57K |
|
3387
Terns Pharmaceuticals
TERN
$687M
| $39K | ﹤0.01% |
6,601
-3,879
| -37% | -$22.9K |
|
3388
Thryv Holdings
THRY
$552M
| $39K | ﹤0.01% |
1,707
-638
| -27% | -$14.6K |
|
|
UHT
3389
Universal Health Realty Income Trust
UHT
$583M
| $39K | ﹤0.01% |
910
-2,399
| -72% | -$103K |
|
|
QVCGB
3390
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
| $39K | ﹤0.01% |
+116
| New | +$39K |
|
|
SURF
3391
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $39K | ﹤0.01% |
37,300
+32,306
| +647% | +$33.8K |
|
|
DZSI
3392
DELISTED
DZS Inc. Common Stock
DZSI
| $39K | ﹤0.01% |
3,418
+2,893
| +551% | +$33K |
|
3393
Acco Brands
ACCO
$379M
| $38K | ﹤0.01% |
7,798
+4,197
| +117% | +$20.5K |
|
3394
Agilysys
AGYS
$3B
| $38K | ﹤0.01% |
689
-103
| -13% | -$5.68K |
|
3395
Anika Therapeutics
ANIK
$128M
| $38K | ﹤0.01% |
1,601
+608
| +61% | +$14.4K |
|
3396
Business First Bancshares
BFST
$727M
| $38K | ﹤0.01% |
1,778
+88
| +5% | +$1.88K |
|
3397
BRF SA
BRFS
$6.6B
| $38K | ﹤0.01% |
16,636
+6,509
| +64% | +$14.9K |
|
3398
Erasca
ERAS
$516M
| $38K | ﹤0.01% |
4,910
-1,039
| -17% | -$8.04K |
|
3399
Ethan Allen Interiors
ETD
$753M
| $38K | ﹤0.01% |
1,783
+553
| +45% | +$11.8K |
|
3400
First National Corp
FXNC
$216M
| $38K | ﹤0.01% |
2,522
+1,885
| +296% | +$28.4K |
|